ISLR and familial pancreatic carcinoma: We recently showed that AM80 drug treatment increased the expression of meflin, a marker of tumor-restraining CAFs,77 decreased the stiffness of cancer tissues, and enhanced the effects of chemotherapy in a mouse pancreatic cancer model.9